JPRN-UMIN000035961
Completed
未知
Randomized controlled trial on immunomodulatory Effects of Azithromycin in Children with Steroid Dependent Nephrotic Syndrome - Immunomodulatory effect of azithromycin on SDNS
Conditionscomplteted
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- complteted
- Sponsor
- Cairo University
- Enrollment
- 57
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •\- Patients have received immunosuppressive or cytotoxic drugs other than steroids. \- Patients with impaired liver functions, or with baseline risk of cardiovascular disease (i.e. prolonged QT syndrome, abnormally slow heart rate, congenital or acquired cardiac diseases or low levels of potassium and magnesium) \- Secondary nephrotic syndrome
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Immunomodulatory action of Balchaturbhadra Syrup in Lowering Down Morbidity in childreCTRI/2022/09/045142niversity Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur
Completed
Not Applicable
A randomized controlled trial of immune-enhancing enteral feeding on immunologic and nutritional status in tube-fed patientsmalnutritionJPRN-UMIN000001326Morinaga Milk Industry Co., Ltd.126
Active, not recruiting
Phase 1
Randomized and controlled clinical trial of the efficacy and safety of the use of lidocaine and magnesium sulfate for lung resection surgery using Video-Assisted Thoracic Surgery (VATS)CTIS2023-509503-33-00Clinica Universidad De Navarra128
Active, not recruiting
Phase 1
A study to assess the efficacy of a cardiac drug and a anti-inflammatory drug in patients with post-acute inflammatory heart disease due to COVID-19Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imagingMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10007650Term: Cardiovascular disorder NOSSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2022-001682-12-ATGoethe University Frankfurt280
Recruiting
Phase 3
A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 PneumoniaCTRI/2020/08/027475Cadila Pharmaceuticals Limited